News for Optimi Health Corp. (OPTI.CN)

Optimi Health Corp. , a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer, specializing in controlled substances such as botanical psilocybin and MDMA, is pleased to...

Optimi Health Awarded Drug Establishment Licence From Health Canada

Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research

VANCOUVER, British Columbia, April 23, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed…

Three batches tested and validated by third-party laboratoryVANCOUVER, British Columbia, April 15, 2024 -- Optimi Health Corp. , a leading Health Canada licensed psychedelics pharmaceutical...

VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) —

Optimi CEO Bill Ciprick to speak on the future of GMP psychedelic manufacturing

First tranche of investment led by co-founders JJ Wilson and Dane StevensVANCOUVER, British Columbia, Feb. 28, 2024 -- Optimi Health Corp. , a Health Canada licensed drug researcher and...

Company shares behind-the-scenes look at its GMP MDMA encapsulation and production process

Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video Company shares behind-the-scenes look at its GMP MDMA encapsulation and production process GlobeNewswire February 12, 2024 VANCOUVER, British Columbia, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN)...

/PRNewswire/ -- Young adults are using more hallucinogens than ever. According to a National Institute of Health survey, the amount of people between age 19 to...

/PRNewswire/ -- Toronto's Center for Addiction and Mental Health (CAMH) just received the first-ever federal grant to study whether the active component of...